Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07335939

Late-term Abortions Between 14 and 16 Weeks of Gestation: Comparison of Hemorrhagic Risks in Surgical vs. Medical Abortions

Since the extension of the legal abortion limit to 16 weeks by the law of March 2, 2022, we must adapt our care to reduce the risks associated with this procedure. According to the French National Authority for Health (HAS), all abortions after 9 weeks of gestation should be performed surgically, but the French National College of Gynecologists and Obstetricians (CNGOF) indicates that each patient should have the choice of method regardless of the gestational age at the time of the abortion.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Age range

18 year–40 year

Sex eligibility

Female

Study type

Observational

Primary location

Service de Gynécologie-Obstétrique - CHU de Strasbourg - France

Strasbourg, 67091, France

Location status: Recruiting

Location contact

Charlotte BORDES, MD

SUB_INVESTIGATOR

Georges Emmanuel ROTH

SUB_INVESTIGATOR

Victor Gabriele, MD

CONTACT

[email protected]

33 3 69 55 34 04

Victor Gabriele, MD

PRINCIPAL_INVESTIGATOR

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult woman
  • Single or multiple pregnancy
  • Undergoing an abortion between 14 and 16 weeks of gestation at the Strasbourg University Hospital between March 2, 2022, and March 2, 2026

Exclusion criteria

  • Missed Pregnancy
  • Term < 14 Weeks of Gestation or > 16 Weeks of Gestation

Treatment and study plan

Primary outcomes

  1. Bleeding (in cc)

    Time frame: During surgery

    Bleeding > 500 cc means a very large blood loss

Study contacts

Contact information is provided by the study sponsor or research team.

Victor Gabrielle, MD

CONTACT

[email protected]

33 3 69 55 34 04

Sponsors and collaborators

Lead sponsor

University Hospital, Strasbourg, France

Other

Registry information

Acronym: IVG-Tardives

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Jan 13, 2026
Registry last updated
Jan 13, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.